- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Tafenoquine is an aminoquinoline that is used in combination with other antimalarials for the prevention of relapse of Plasmodium vivax malaria and by itself as prophylaxis against all species of malaria. Tafenoquine has been linked to low rates of transient and asymptomatic serum enzyme elevations during therapy but has not been associated with instances of clinically apparent acute liver injury.
According to our latest study, the global Tafenoquine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Tafenoquine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Tafenoquine market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Gram), 2018-2029
Global Tafenoquine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Gram), 2018-2029
Global Tafenoquine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Gram), 2018-2029
Global Tafenoquine market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Gram), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Tafenoquine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Tafenoquine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GlaxoSmithKline Pharmaceuticals (GSK), J & K Scientific LTD, BOC Sciences, WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. and Pharmacodia (Beijing) Co.,Ltd, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Tafenoquine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Powder
Pills
Market segment by Application
Radical Cure of P.vivax
P. falciparum Treatment
Prevention of Malaria Relapse
Major players covered
GlaxoSmithKline Pharmaceuticals (GSK)
J & K Scientific LTD
BOC Sciences
WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
Pharmacodia (Beijing) Co.,Ltd
Amadis Chemical Company Limited
Merck
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Tafenoquine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Tafenoquine, with price, sales, revenue and global market share of Tafenoquine from 2018 to 2023.
Chapter 3, the Tafenoquine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tafenoquine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Tafenoquine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Tafenoquine.
Chapter 14 and 15, to describe Tafenoquine sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Tafenoquine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Tafenoquine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Powder
1.3.3 Pills
1.4 Market Analysis by Application
1.4.1 Overview: Global Tafenoquine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Radical Cure of P.vivax
1.4.3 P. falciparum Treatment
1.4.4 Prevention of Malaria Relapse
1.5 Global Tafenoquine Market Size & Forecast
1.5.1 Global Tafenoquine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Tafenoquine Sales Quantity (2018-2029)
1.5.3 Global Tafenoquine Average Price (2018-2029)
2 Manufacturers Profiles
2.1 GlaxoSmithKline Pharmaceuticals (GSK)
2.1.1 GlaxoSmithKline Pharmaceuticals (GSK) Details
2.1.2 GlaxoSmithKline Pharmaceuticals (GSK) Major Business
2.1.3 GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Product and Services
2.1.4 GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 GlaxoSmithKline Pharmaceuticals (GSK) Recent Developments/Updates
2.2 J & K Scientific LTD
2.2.1 J & K Scientific LTD Details
2.2.2 J & K Scientific LTD Major Business
2.2.3 J & K Scientific LTD Tafenoquine Product and Services
2.2.4 J & K Scientific LTD Tafenoquine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 J & K Scientific LTD Recent Developments/Updates
2.3 BOC Sciences
2.3.1 BOC Sciences Details
2.3.2 BOC Sciences Major Business
2.3.3 BOC Sciences Tafenoquine Product and Services
2.3.4 BOC Sciences Tafenoquine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 BOC Sciences Recent Developments/Updates
2.4 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
2.4.1 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Details
2.4.2 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Major Business
2.4.3 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Product and Services
2.4.4 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Recent Developments/Updates
2.5 Pharmacodia (Beijing) Co.,Ltd
2.5.1 Pharmacodia (Beijing) Co.,Ltd Details
2.5.2 Pharmacodia (Beijing) Co.,Ltd Major Business
2.5.3 Pharmacodia (Beijing) Co.,Ltd Tafenoquine Product and Services
2.5.4 Pharmacodia (Beijing) Co.,Ltd Tafenoquine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Pharmacodia (Beijing) Co.,Ltd Recent Developments/Updates
2.6 Amadis Chemical Company Limited
2.6.1 Amadis Chemical Company Limited Details
2.6.2 Amadis Chemical Company Limited Major Business
2.6.3 Amadis Chemical Company Limited Tafenoquine Product and Services
2.6.4 Amadis Chemical Company Limited Tafenoquine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Amadis Chemical Company Limited Recent Developments/Updates
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business
2.7.3 Merck Tafenoquine Product and Services
2.7.4 Merck Tafenoquine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Merck Recent Developments/Updates
3 Competitive Environment: Tafenoquine by Manufacturer
3.1 Global Tafenoquine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Tafenoquine Revenue by Manufacturer (2018-2023)
3.3 Global Tafenoquine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Tafenoquine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Tafenoquine Manufacturer Market Share in 2022
3.4.2 Top 6 Tafenoquine Manufacturer Market Share in 2022
3.5 Tafenoquine Market: Overall Company Footprint Analysis
3.5.1 Tafenoquine Market: Region Footprint
3.5.2 Tafenoquine Market: Company Product Type Footprint
3.5.3 Tafenoquine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Tafenoquine Market Size by Region
4.1.1 Global Tafenoquine Sales Quantity by Region (2018-2029)
4.1.2 Global Tafenoquine Consumption Value by Region (2018-2029)
4.1.3 Global Tafenoquine Average Price by Region (2018-2029)
4.2 North America Tafenoquine Consumption Value (2018-2029)
4.3 Europe Tafenoquine Consumption Value (2018-2029)
4.4 Asia-Pacific Tafenoquine Consumption Value (2018-2029)
4.5 South America Tafenoquine Consumption Value (2018-2029)
4.6 Middle East and Africa Tafenoquine Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Tafenoquine Sales Quantity by Type (2018-2029)
5.2 Global Tafenoquine Consumption Value by Type (2018-2029)
5.3 Global Tafenoquine Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Tafenoquine Sales Quantity by Application (2018-2029)
6.2 Global Tafenoquine Consumption Value by Application (2018-2029)
6.3 Global Tafenoquine Average Price by Application (2018-2029)
7 North America
7.1 North America Tafenoquine Sales Quantity by Type (2018-2029)
7.2 North America Tafenoquine Sales Quantity by Application (2018-2029)
7.3 North America Tafenoquine Market Size by Country
7.3.1 North America Tafenoquine Sales Quantity by Country (2018-2029)
7.3.2 North America Tafenoquine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Tafenoquine Sales Quantity by Type (2018-2029)
8.2 Europe Tafenoquine Sales Quantity by Application (2018-2029)
8.3 Europe Tafenoquine Market Size by Country
8.3.1 Europe Tafenoquine Sales Quantity by Country (2018-2029)
8.3.2 Europe Tafenoquine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Tafenoquine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Tafenoquine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Tafenoquine Market Size by Region
9.3.1 Asia-Pacific Tafenoquine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Tafenoquine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Tafenoquine Sales Quantity by Type (2018-2029)
10.2 South America Tafenoquine Sales Quantity by Application (2018-2029)
10.3 South America Tafenoquine Market Size by Country
10.3.1 South America Tafenoquine Sales Quantity by Country (2018-2029)
10.3.2 South America Tafenoquine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Tafenoquine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Tafenoquine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Tafenoquine Market Size by Country
11.3.1 Middle East & Africa Tafenoquine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Tafenoquine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Tafenoquine Market Drivers
12.2 Tafenoquine Market Restraints
12.3 Tafenoquine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Tafenoquine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Tafenoquine
13.3 Tafenoquine Production Process
13.4 Tafenoquine Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Tafenoquine Typical Distributors
14.3 Tafenoquine Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Tafenoquine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Tafenoquine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. GlaxoSmithKline Pharmaceuticals (GSK) Basic Information, Manufacturing Base and Competitors
Table 4. GlaxoSmithKline Pharmaceuticals (GSK) Major Business
Table 5. GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Product and Services
Table 6. GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Sales Quantity (Tons), Average Price (US$/Gram), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. GlaxoSmithKline Pharmaceuticals (GSK) Recent Developments/Updates
Table 8. J & K Scientific LTD Basic Information, Manufacturing Base and Competitors
Table 9. J & K Scientific LTD Major Business
Table 10. J & K Scientific LTD Tafenoquine Product and Services
Table 11. J & K Scientific LTD Tafenoquine Sales Quantity (Tons), Average Price (US$/Gram), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. J & K Scientific LTD Recent Developments/Updates
Table 13. BOC Sciences Basic Information, Manufacturing Base and Competitors
Table 14. BOC Sciences Major Business
Table 15. BOC Sciences Tafenoquine Product and Services
Table 16. BOC Sciences Tafenoquine Sales Quantity (Tons), Average Price (US$/Gram), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. BOC Sciences Recent Developments/Updates
Table 18. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 19. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Major Business
Table 20. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Product and Services
Table 21. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Sales Quantity (Tons), Average Price (US$/Gram), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Recent Developments/Updates
Table 23. Pharmacodia (Beijing) Co.,Ltd Basic Information, Manufacturing Base and Competitors
Table 24. Pharmacodia (Beijing) Co.,Ltd Major Business
Table 25. Pharmacodia (Beijing) Co.,Ltd Tafenoquine Product and Services
Table 26. Pharmacodia (Beijing) Co.,Ltd Tafenoquine Sales Quantity (Tons), Average Price (US$/Gram), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Pharmacodia (Beijing) Co.,Ltd Recent Developments/Updates
Table 28. Amadis Chemical Company Limited Basic Information, Manufacturing Base and Competitors
Table 29. Amadis Chemical Company Limited Major Business
Table 30. Amadis Chemical Company Limited Tafenoquine Product and Services
Table 31. Amadis Chemical Company Limited Tafenoquine Sales Quantity (Tons), Average Price (US$/Gram), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Amadis Chemical Company Limited Recent Developments/Updates
Table 33. Merck Basic Information, Manufacturing Base and Competitors
Table 34. Merck Major Business
Table 35. Merck Tafenoquine Product and Services
Table 36. Merck Tafenoquine Sales Quantity (Tons), Average Price (US$/Gram), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Merck Recent Developments/Updates
Table 38. Global Tafenoquine Sales Quantity by Manufacturer (2018-2023) & (Tons)
Table 39. Global Tafenoquine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 40. Global Tafenoquine Average Price by Manufacturer (2018-2023) & (US$/Gram)
Table 41. Market Position of Manufacturers in Tafenoquine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 42. Head Office and Tafenoquine Production Site of Key Manufacturer
Table 43. Tafenoquine Market: Company Product Type Footprint
Table 44. Tafenoquine Market: Company Product Application Footprint
Table 45. Tafenoquine New Market Entrants and Barriers to Market Entry
Table 46. Tafenoquine Mergers, Acquisition, Agreements, and Collaborations
Table 47. Global Tafenoquine Sales Quantity by Region (2018-2023) & (Tons)
Table 48. Global Tafenoquine Sales Quantity by Region (2024-2029) & (Tons)
Table 49. Global Tafenoquine Consumption Value by Region (2018-2023) & (USD Million)
Table 50. Global Tafenoquine Consumption Value by Region (2024-2029) & (USD Million)
Table 51. Global Tafenoquine Average Price by Region (2018-2023) & (US$/Gram)
Table 52. Global Tafenoquine Average Price by Region (2024-2029) & (US$/Gram)
Table 53. Global Tafenoquine Sales Quantity by Type (2018-2023) & (Tons)
Table 54. Global Tafenoquine Sales Quantity by Type (2024-2029) & (Tons)
Table 55. Global Tafenoquine Consumption Value by Type (2018-2023) & (USD Million)
Table 56. Global Tafenoquine Consumption Value by Type (2024-2029) & (USD Million)
Table 57. Global Tafenoquine Average Price by Type (2018-2023) & (US$/Gram)
Table 58. Global Tafenoquine Average Price by Type (2024-2029) & (US$/Gram)
Table 59. Global Tafenoquine Sales Quantity by Application (2018-2023) & (Tons)
Table 60. Global Tafenoquine Sales Quantity by Application (2024-2029) & (Tons)
Table 61. Global Tafenoquine Consumption Value by Application (2018-2023) & (USD Million)
Table 62. Global Tafenoquine Consumption Value by Application (2024-2029) & (USD Million)
Table 63. Global Tafenoquine Average Price by Application (2018-2023) & (US$/Gram)
Table 64. Global Tafenoquine Average Price by Application (2024-2029) & (US$/Gram)
Table 65. North America Tafenoquine Sales Quantity by Type (2018-2023) & (Tons)
Table 66. North America Tafenoquine Sales Quantity by Type (2024-2029) & (Tons)
Table 67. North America Tafenoquine Sales Quantity by Application (2018-2023) & (Tons)
Table 68. North America Tafenoquine Sales Quantity by Application (2024-2029) & (Tons)
Table 69. North America Tafenoquine Sales Quantity by Country (2018-2023) & (Tons)
Table 70. North America Tafenoquine Sales Quantity by Country (2024-2029) & (Tons)
Table 71. North America Tafenoquine Consumption Value by Country (2018-2023) & (USD Million)
Table 72. North America Tafenoquine Consumption Value by Country (2024-2029) & (USD Million)
Table 73. Europe Tafenoquine Sales Quantity by Type (2018-2023) & (Tons)
Table 74. Europe Tafenoquine Sales Quantity by Type (2024-2029) & (Tons)
Table 75. Europe Tafenoquine Sales Quantity by Application (2018-2023) & (Tons)
Table 76. Europe Tafenoquine Sales Quantity by Application (2024-2029) & (Tons)
Table 77. Europe Tafenoquine Sales Quantity by Country (2018-2023) & (Tons)
Table 78. Europe Tafenoquine Sales Quantity by Country (2024-2029) & (Tons)
Table 79. Europe Tafenoquine Consumption Value by Country (2018-2023) & (USD Million)
Table 80. Europe Tafenoquine Consumption Value by Country (2024-2029) & (USD Million)
Table 81. Asia-Pacific Tafenoquine Sales Quantity by Type (2018-2023) & (Tons)
Table 82. Asia-Pacific Tafenoquine Sales Quantity by Type (2024-2029) & (Tons)
Table 83. Asia-Pacific Tafenoquine Sales Quantity by Application (2018-2023) & (Tons)
Table 84. Asia-Pacific Tafenoquine Sales Quantity by Application (2024-2029) & (Tons)
Table 85. Asia-Pacific Tafenoquine Sales Quantity by Region (2018-2023) & (Tons)
Table 86. Asia-Pacific Tafenoquine Sales Quantity by Region (2024-2029) & (Tons)
Table 87. Asia-Pacific Tafenoquine Consumption Value by Region (2018-2023) & (USD Million)
Table 88. Asia-Pacific Tafenoquine Consumption Value by Region (2024-2029) & (USD Million)
Table 89. South America Tafenoquine Sales Quantity by Type (2018-2023) & (Tons)
Table 90. South America Tafenoquine Sales Quantity by Type (2024-2029) & (Tons)
Table 91. South America Tafenoquine Sales Quantity by Application (2018-2023) & (Tons)
Table 92. South America Tafenoquine Sales Quantity by Application (2024-2029) & (Tons)
Table 93. South America Tafenoquine Sales Quantity by Country (2018-2023) & (Tons)
Table 94. South America Tafenoquine Sales Quantity by Country (2024-2029) & (Tons)
Table 95. South America Tafenoquine Consumption Value by Country (2018-2023) & (USD Million)
Table 96. South America Tafenoquine Consumption Value by Country (2024-2029) & (USD Million)
Table 97. Middle East & Africa Tafenoquine Sales Quantity by Type (2018-2023) & (Tons)
Table 98. Middle East & Africa Tafenoquine Sales Quantity by Type (2024-2029) & (Tons)
Table 99. Middle East & Africa Tafenoquine Sales Quantity by Application (2018-2023) & (Tons)
Table 100. Middle East & Africa Tafenoquine Sales Quantity by Application (2024-2029) & (Tons)
Table 101. Middle East & Africa Tafenoquine Sales Quantity by Region (2018-2023) & (Tons)
Table 102. Middle East & Africa Tafenoquine Sales Quantity by Region (2024-2029) & (Tons)
Table 103. Middle East & Africa Tafenoquine Consumption Value by Region (2018-2023) & (USD Million)
Table 104. Middle East & Africa Tafenoquine Consumption Value by Region (2024-2029) & (USD Million)
Table 105. Tafenoquine Raw Material
Table 106. Key Manufacturers of Tafenoquine Raw Materials
Table 107. Tafenoquine Typical Distributors
Table 108. Tafenoquine Typical Customers
List of Figures
Figure 1. Tafenoquine Picture
Figure 2. Global Tafenoquine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Tafenoquine Consumption Value Market Share by Type in 2022
Figure 4. Powder Examples
Figure 5. Pills Examples
Figure 6. Global Tafenoquine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Tafenoquine Consumption Value Market Share by Application in 2022
Figure 8. Radical Cure of P.vivax Examples
Figure 9. P. falciparum Treatment Examples
Figure 10. Prevention of Malaria Relapse Examples
Figure 11. Global Tafenoquine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Tafenoquine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Tafenoquine Sales Quantity (2018-2029) & (Tons)
Figure 14. Global Tafenoquine Average Price (2018-2029) & (US$/Gram)
Figure 15. Global Tafenoquine Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Tafenoquine Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Tafenoquine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Tafenoquine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Tafenoquine Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Tafenoquine Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Tafenoquine Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Tafenoquine Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Tafenoquine Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Tafenoquine Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Tafenoquine Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Tafenoquine Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Tafenoquine Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Tafenoquine Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Tafenoquine Average Price by Type (2018-2029) & (US$/Gram)
Figure 30. Global Tafenoquine Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Tafenoquine Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Tafenoquine Average Price by Application (2018-2029) & (US$/Gram)
Figure 33. North America Tafenoquine Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Tafenoquine Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Tafenoquine Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Tafenoquine Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Tafenoquine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Tafenoquine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Tafenoquine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Tafenoquine Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Tafenoquine Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Tafenoquine Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Tafenoquine Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Tafenoquine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Tafenoquine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Tafenoquine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Tafenoquine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Tafenoquine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Tafenoquine Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Tafenoquine Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Tafenoquine Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Tafenoquine Consumption Value Market Share by Region (2018-2029)
Figure 53. China Tafenoquine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Tafenoquine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Tafenoquine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Tafenoquine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Tafenoquine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Tafenoquine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Tafenoquine Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Tafenoquine Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Tafenoquine Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Tafenoquine Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Tafenoquine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Tafenoquine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Tafenoquine Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Tafenoquine Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Tafenoquine Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Tafenoquine Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Tafenoquine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Tafenoquine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Tafenoquine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Tafenoquine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Tafenoquine Market Drivers
Figure 74. Tafenoquine Market Restraints
Figure 75. Tafenoquine Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Tafenoquine in 2022
Figure 78. Manufacturing Process Analysis of Tafenoquine
Figure 79. Tafenoquine Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
